Tissue Phenomics Blog

5B_Her2-classified.jpg

Posts by Topic

see all

Topics:  Immunotherapy, tissue phenomics, tissue biomarkers, cancer immunotherapy, diagnostics, tissue-based diagnostics, io-panel

The Power of Predictive Quantitative Tissue-Based Diagnostics in Cancer Immunotherapy

Nov 21, 2017 8:00:00 AM

The American Society of Clinical Oncology named Immunotherapy 2.0 “Advance of the Year” at its 2017 Annual Meeting in Chicago, IL. This recognition comes after decades of incremental progress in our understanding of how the human immune system interacts with cancerous lesions. It also is the culmination of recent successes with checkpoint inhibitor therapy that promised dramatic changes in clinical practice and the approach to cancer treatment. What started with cutaneous melanoma in 2011 is now rapidly showing remarkable results also in other
cancer types. Just over the past year, the Food and Drug Administration (FDA) approved the use of checkpoint inhibitors in five additional cancer indications: lung, head and neck, bladder, kidney, and classical Hodgkin lymphoma.

Read More